1.
Hussain S, Imtiaz N, Amin MA, Khan S, Kakar S. COMPARISON OF TWO WIDELY USED ATYPICAL ANTIPSYCHOTICS OLANZAPINE VERSUS RISPERIDONE IN TERMS OF METABOLIC OUTCOMES. PAFMJ [Internet]. 2021 Jan. 27 [cited 2024 Apr. 29];71(Suppl-1):S147-52. Available from: https://www.pafmj.org/PAFMJ/article/view/3382